\begin{tabular}{lccccccccc}
   \hline
 
         \multicolumn{1}{l}{Mock} & \multicolumn{1}{c}{Tertile}   & \multicolumn{1}{c}{No. cases /}   & \multicolumn{1}{c}{Attack}   & \multicolumn{2}{c}{HR per 10-fold incr.}                     & \multicolumn{1}{c}{P-value}   & \multicolumn{1}{c}{Overall P-}      & \multicolumn{1}{c}{Overall q-}   & \multicolumn{1}{c}{Overall} \\ 
         \multicolumn{1}{l}{Immunologic Marker}            & \multicolumn{1}{c}{}          & \multicolumn{1}{c}{No. at-risk**} & \multicolumn{1}{c}{rate}   & \multicolumn{1}{c}{Pt. Est.} & \multicolumn{1}{c}{95\% CI} & \multicolumn{1}{c}{(2-sided)} & \multicolumn{1}{c}{value***} & \multicolumn{1}{c}{value} & \multicolumn{1}{c}{FWER} \\ 
         \hline
 
            
 \multicolumn{8}{l}{Day 57} \\ 
Anti Spike IgG & Lower & 66/4,430 & 0.0149 & 1 & N/A & N/A & $<$0.001 & $<$0.001 & $<$0.001 \\ 
  (IU/ml) & Middle & 4/4,412 & 0.0009 & 0.07 & (0.02-0.20) & $<$0.001 &     &     &     \\ 
   & Upper & 1/4,456 & 0.0002 & 0.01 & (0.00-0.06) & $<$0.001 &     &     &     \\ 
  Anti RBD IgG & Lower & 47/4,430 & 0.0106 & 1 & N/A & N/A & $<$0.001 & $<$0.001 & $<$0.001 \\ 
  (IU/ml) & Middle & 17/4,432 & 0.0038 & 0.46 & (0.23-0.90) & 0.023 &     &     &     \\ 
   & Upper & 7/4,435 & 0.0016 & 0.10 & (0.04-0.23) & $<$0.001 &     &     &     \\ 
  Pseudovirus-nAb & Lower & 48/4,424 & 0.0108 & 1 & N/A & N/A & $<$0.001 & $<$0.001 & $<$0.001 \\ 
  ID50 & Middle & 16/4,440 & 0.0036 & 0.31 & (0.16-0.61) & 0.001 &     &     &     \\ 
   & Upper & 7/4,433 & 0.0016 & 0.11 & (0.05-0.27) & $<$0.001 &     &     &     \\ 
  Pseudovirus-nAb & Lower & 57/4,431 & 0.0129 & 1 & N/A & N/A & $<$0.001 & $<$0.001 & $<$0.001 \\ 
  ID80 & Middle & 11/4,426 & 0.0025 & 0.22 & (0.11-0.44) & $<$0.001 &     &     &     \\ 
   & Upper & 3/4,440 & 0.0007 & 0.04 & (0.01-0.14) & $<$0.001 &     &     &     \\ 
          
 \multicolumn{8}{l}{} \\ 
        
 \multicolumn{8}{l}{Fold-rise} \\ 
Anti Spike IgG & Lower & 63/4,429 & 0.0142 & 1 & N/A & N/A & $<$0.001 & $<$0.001 & $<$0.001 \\ 
  (IU/ml) & Middle & 7/4,435 & 0.0016 & 0.13 & (0.06-0.31) & $<$0.001 &     &     &     \\ 
   & Upper & 1/4,433 & 0.0002 & 0.01 & (0.00-0.05) & $<$0.001 &     &     &     \\ 
  Anti RBD IgG & Lower & 49/4,437 & 0.0110 & 1 & N/A & N/A & $<$0.001 & $<$0.001 & $<$0.001 \\ 
  (IU/ml) & Middle & 19/4,437 & 0.0043 & 0.32 & (0.17-0.59) & $<$0.001 &     &     &     \\ 
   & Upper & 3/4,424 & 0.0007 & 0.03 & (0.01-0.12) & $<$0.001 &     &     &     \\ 
  Pseudovirus-nAb & Lower & 49/4,460 & 0.0110 & 1 & N/A & N/A & $<$0.001 & $<$0.001 & $<$0.001 \\ 
  ID50 & Middle & 13/4,438 & 0.0029 & 0.31 & (0.15-0.62) & 0.001 &     &     &     \\ 
   & Upper & 9/4,400 & 0.0020 & 0.16 & (0.07-0.36) & $<$0.001 &     &     &     \\ 
  Pseudovirus-nAb & Lower & 52/4,432 & 0.0117 & 1 & N/A & N/A & $<$0.001 & $<$0.001 & $<$0.001 \\ 
  ID80 & Middle & 16/4,410 & 0.0036 & 0.30 & (0.16-0.56) & $<$0.001 &     &     &     \\ 
   & Upper & 3/4,455 & 0.0007 & 0.05 & (0.01-0.17) & $<$0.001 &     &     &     \\ 
    
 \multicolumn{8}{l}{} \\ 

 \multicolumn{2}{l}{Placebo} & 710/13,326&0.0533&\multicolumn{4}{l}{}  \\ 
 \hline
\end{tabular}
